Skip to main content
. 2018 Aug;4(4):a002550. doi: 10.1101/mcs.a002550

Table 1.

FANCA and ALK mutation details

Gene Description Somatic Cytoband Pos (hg19/GRCh37) Ref Var Coverage at mutation site Var allele fraction Variant function on protein Change cDNA/protein Predicted impact on protein function Presence public databases
SIFT PP2 LRT dbSNP(132) 1000 Genome esp6500 all Cosmic ClinVar HGMD
FANCA Fanconi anemia group A protein No 16q24.3 Chr 16:89805118 T G 80× 43% Splicing FANCA: NM_000135.2:exon43:c.4261-2A>C - - - - - - - - CS04812
FANCA Fanconi anemia group A protein No 16q24.3 Chr 16:89831348 G A 185× 49% Nonsynonymous SNV FANCA:NM_000135.2:exon28:c.C2728T:p.L910F Deleterious Probably damaging Deleterious - - - 4483710 - -
FANCA Fanconi anemia group A protein No 16q24.3 Chr 16:89871709 C T 81× 62% Nonsynonymous SNV FANCA:NM_000135.2:exon7:c.G688A:p.V230I Nondeleterious Benign Neutral rs144560850 - 0.000231 - 321366 -
ALK ALK tyrosine kinase receptor Yes 2p23.2 Chr 2:29445213 A G 83× 40% Nonsynonymous SNV ALK:NM_004304.4:exon22:c.T3512C:p.I1171T - Probably damaging Deleterious - - - 4381100 - -

Variant specific information including position, transcript-ID, coverage, and presence in publically available databases.